Kymera Therapeutics, Inc. (KYMR) Operating Lease, Liability USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Kymera Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2020 to 2024.
  • Kymera Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $84.7 M, a 27.6% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $84.7 M +$18.3 M +27.6% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $82.1 M +$67.4 M +459% Dec 31, 2023 10-K 2024-02-22
Q3 2023 $79.2 M +$64.2 M +430% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $73.1 M +$57.9 M +381% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $66.4 M +$51 M +330% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $14.7 M -$1 M -6.4% Dec 31, 2022 10-K 2023-02-23
Q3 2022 $14.9 M -$959 K -6.03% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $15.2 M -$915 K -5.68% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $15.5 M -$874 K -5.35% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $15.7 M -$1.02 M -6.08% Dec 31, 2021 10-K 2022-02-24
Q3 2021 $15.9 M -$1.15 M -6.76% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $16.1 M Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $16.3 M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $16.7 M Dec 31, 2020 10-K 2021-03-11
Q3 2020 $17.1 M Sep 30, 2020 10-Q 2020-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.